Hereditary sensorineural hearing loss: Advances in molecular genetics and mutation analysis

Expert Review of Molecular Diagnostics

Volumn 6, Issue 3, 2006, Pages 375-386

  Schrijver, Iris ^a   Gardner, Phyllis ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

APEX; Connexin; Deafness; Hearing loss; Hearing loss testing; Pendred; SNHL; Testing algorithm

Indexed keywords

CONNEXIN 26; CONNEXIN 30; KCNQ4 VOLTAGE GATED POTASSIUM CHANNEL; OCTAMER TRANSCRIPTION FACTOR 6; PENDRIN; POTASSIUM CHANNEL; UNCLASSIFIED DRUG; GAP JUNCTION PROTEIN;

ALGORITHM; GENE MUTATION; GENETIC DISORDER; HUMAN; MOLECULAR GENETICS; PERCEPTION DEAFNESS; REVIEW; BIOLOGICAL MODEL; DIAGNOSTIC PROCEDURE; GENE DELETION; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; HOMOZYGOTE; MUTATION; NUCLEOTIDE SEQUENCE; PHENOTYPE;

ALGORITHMS; CONNEXINS; DNA MUTATIONAL ANALYSIS; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; HEARING LOSS, SENSORINEURAL; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MODELS, BIOLOGICAL; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; PHENOTYPE;

EID: 33745947419     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.6.3.375     Document Type: Review

References (82)

1. Petit C, Levilliers J, Marlin S, Hardelin J-P. Hereditary hearing loss. In: The Metabolic & Molecular Bases of Inherited Disease. Eighth Edition, Volume IV. Scriver CR, Beaudet AL, Sly WS, Valle D (Eds), McGraw Hill, NY, USA, 6281-6328 (2001).
2. White KR. Early hearing detection and intervention programs: opportunities for genetic services. Am. J. Med. Genet. 130(1), 29-36 (2004).
3. Mason JA, Herrmann KR. Universal infant hearing screening by automated auditory brainstem response measurement. Pediatrics 101, 221-228 (1998).
4. Parving A. The need for universal neonatal hearing screening - some aspects of epidemiology and identification. Acta Paediatr. Suppl. 88, 69-72 (1999).
5. Marres HA. Congenital abnormalities of the inner ear. In: Diseases of the Ear. Ludman H, Wright T (Eds), Arnold & Oxford University Press, Bath, UK, 288-296 (1998).
6. Friedman TB, Griffith AJ. Human non-syndromic sensorineural deafness. Annu. Rev. Genomics Hum. Genet. 4, 341-402 (2003) •• Comprehensive review of the biological roles of 30 genes involved in dominant and recessive nonsyndromic sensorineural hearing loss.
7. Ming JE, Muenke M. Multiple hits during early embryonic development: digenic diseases and holoprosencephaly. Am. J. Hum. Genet. 71, 1017-1032 (2002).
8. Van Camp G, Willems PJ, Smith RJ. Non-syndromic hearing impairment: unparalleled heterogeneity. Am. J. Hum. Genet. 60, 758-764 (1997).
9. ACMG. Genetics evaluation guidelines for the etiologic diagnosis of congenital hearing loss. Genetic Evaluation of Congenital Hearing Loss Expert Panel. ACMG statement. Genet. Med. 4, 162-171 (2002). • Guideline to genetic services for congenital hearing loss.
10. Cryns K, Van Camp G. Deafness genes and their diagnostic applications. Audiol. Neurootol. 9(1), 2-22 (2004).
11. Li XC, Friedman RA. Non-syndromic hereditary hearing loss. Otolaryngol. Clin. North Am. 35, 275-285 (2002).
12. Van Laer L, Cryns K, Smith RJ, Van Camp G. Non-syndromic hearing loss. Ear Hear. 24, 275-288 (2003).
13. Morton CC. Gene discovery in the auditory system using a tissue specific approach. Am. J. Med. Genet. A 130, 26-28 (2004).
14. Avraham KB. Mouse models for deafness: lessons for the human inner ear and hearing loss. Ear Hear. 24, 332-341 (2003). • Accessible review of mouse models used as a resource to understand inner ear biology.
15. Guilford P, Ben Arab S, Blanchard S et al. A non-syndrome form of neurosensory, recessive deafness maps to the pericentromeric region of chromosome 13q. Nature Genet. 6(1), 24-28 (1994).
16. Kelsell DP, Dunlop J, Stevens HP et al. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 387, 80-83 (1997). •• First paper to describe mutations in the GJB2 gene.
17. Del Castillo I, Moreno-Pelayo MA, Del Castillo FJ et al. Prevalence and evolutionary origins of the del(GJB6-D13S1830) mutation in the DFNB1 locus in hearing-impaired subjects: a multicenter study. Am. J. Hum. Genet. 73, 1452-1458 (2003). •• Comprehensive international exploration of the approximatley 309-kb deletion in GJB6.
18. Estivill X, Fortina P, Surrey S et al. Connexin-26 mutations in sporadic and inherited sensorineural deafness. Lancet 351, 394-398 (1998).
19. Morell RJ, Kim HJ, Hood LJ et al. Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with non-syndromic recessive deafness. N. Engl. J. Med. 339(21), 1500-1505 (1998).
20. Azaiez H, Chamberlin GP, Fischer SM et al. GJB2: the spectrum of deafness-causing allele variants and their phenotype. Hum. Mutat. 24(4), 305-311 (2004).
21. Van Laer L, Coucke P, Mueller RF et al. A common founder for the 35delG GJB2 gene mutation in connexin 26 hearing impairment. J. Med. Genet. 38, 515-518 (2001).
22. Green GE, Scott DA, McDonald JM, Woodworth GG, Sheffield VC, Smith RJ. Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. JAMA 281, 2211-2216 (1999).
23. Fitzgerald T, Duva S, Ostrer H et al. The frequency of GJB2 and GJB6 mutations in the New York State newborn population: feasibility of genetic screening for hearing defects. Clin. Genet. 65, 338-342 (2004).
24. Gasparini P, Rabionet R, Barbujani G et al. High carrier frequency of the 35delG deafness mutation in European populations. Eur. J. Hum. Genet. 8, 19-23 (2000).
25. Yan D, Park HJ, Ouyang XM et al. Evidence of a founder effect for the 235delC mutation of GJB2 (connexin 26) in east Asians. Hum. Genet. 114, 44-50 (2003).
26. Feldmann D, Denoyelle F, Loundon N et al. Clinical evidence of the nonpathogenic nature of the M34T variant in the connexin 26 gene. Eur. J. Hum. Genet. 12, 279-284 (2004).
27. Oguchi T, Ohtsuka A, Hashimoto S et al. Clinical features of patients with GJB2 (connexin 26) mutations: severity of hearing loss is correlated with genotypes and protein expression patterns. J. Hum. Genet. 50, 76-83 (2005).
28. Snoeckx RL, Huygen PL, Feldmann D et al. GJB2 mutations and degree of hearing loss: a multicenter study. Am. J. Hum. Genet. 77, 945-957 (2005). •• Large international multicenter study of genotype-phenotype correlations of GJB2 and GJB6 mutations.
29. Grifa A, Wagner CA, D'Ambrosio L et al. Mutations in GJB6 cause non-syndromic autosomal dominant deafness at DFNA3 locus. Nature Genet. 23, 16-18 (1999). • Report of the only known autosomal dominant GJB6 muation.
30. Del Castillo I, Villamar M, Moreno-Pelayo MA et al. A deletion involving the connexin 30 gene in non-syndromic hearing impairment. N. Engl. J. Med. 346, 243-249 (2002).
31. Del Castillo FJ, Rodriguez-Ballesteros M, Alvarez A et al. A novel deletion involving the connexin-30 gene, del(GJB6-d13s1854), found in trans with mutations in the GJB2 gene (connexin-26) in subjects with DFNB1 non-syndromic hearing impairment. J. Med. Genet. 42, 588-594 (2005). • Report of a second deletion in GJB6, identified as a second mutation in individuals with a GJB2 mutation on the opposite allele.
32. Goodenough DA, Goliger JA, Paul DL. Connexins, connexons, and intercellular communication. Annu. Rev. Biochem. 65, 475-502 (1996).
33. Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC. Plasma membrane channels formed by connexins: their regulation and functions. Physiol. Rev. 83, 1359-3400 (2003). • Comprehensive review of connexin gap junctions.
34. Battey JF Jr. Using genetics to understand auditory function and improve diagnosis. Ear Hear. 24, 266-269 (2003).
35. Rabionet R, Gasparini P, Estivill X. Molecular genetics of hearing impairment due to mutations in gap junction genes encoding β connexins. Hum. Mutat. 16, 190-202 (2000).
36. Teubner B, Michel V, Pesch J et al. Connexin30 (GJB6)-deficiency causes severe hearing impairment and lack of endocochlear potential. Hum. Mol. Genet. 12, 13-21 (2003).
37. Zhang Y, Tang W, Ahmad S, Sipp JA, Chen P, Lin X. Gap junction-mediated intercellular biochemical coupling in cochlear supporting cells is required for normal cochlear functions. Proc. Natl Acad. Sci. USA 102, 15201-15206 (2005).
38. Stevenson VA, Ito M, Milunsky JM. Connexin-30 deletion analysis in connexin-26 heterozygotes. Genet. Test. 7, 151-154 (2003).
39. Maestrini E, Korge BP, Ocana-Sierra J et al. A missense mutation in connexin26, D66H, causes mutilating keratoderma with sensorineural deafness (Vohwinkel's syndrome) in three unrelated families. Hum. Mol. Genet. 8, 1237-1243 (1999).
40. Lamartine J, Munhoz Essenfelder G, Kibar Z et al. Mutations in GJB6 cause hidrotic ectodermal dysplasia. Nature Genet. 26, 142-144 (2000).
41. Smith FJ, Morley SM, McLean WH. A novel connexin 30 mutation in Clouston syndrome. J. Invest. Dermatol. 118, 530-532 (2002).
42. Blons H, Feldmann D, Duval V et al. Screening of SLC26A4 (PDS) gene in Pendred's syndrome: a large spectrum of mutations in France and phenotypic heterogeneity. Clin. Genet. 66(4), 333-340 (2004).
43. Everett LA, Glaser B, Beck JC et al. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nature Genet. 17, 411-422 (1997).
44. Li XC, Everett LA, Lalwani AK et al. A mutation in PDS causes non-syndromic recessive deafness. Nature Genet. 18, 215-217 (1998).
45. Park HJ, Shaukat S, Liu XZ et al. Origins and frequencies of SLC26A4 (PDS) mutations in east and south Asians: global implications for the epidemiology of deafness. J. Med. Genet. 40, 242-248 (2003).
46. Fischel-Ghodsian N. Mitochondrial deafness. Ear Hear. 24, 303-313 (2003).
47. Sinnathuray AR, Raut V, Awa A, Magee A, Toner JG. A review of cochlear implantation in mitochondrial sensorineural hearing loss. Otol. Neurotol. 24, 418-426 (2003).
48. Fischel-Ghodsian N. Genetic factors in aminoglycoside toxicity. Pharmacogenomics 6, 27-36 (2005).
49. Sue CM, Tanji K, Hadjigeorgiou G et al. Maternally inherited hearing loss in a large kindred with a novel T7511C mutation in the mitochondrial DNA tRNA(Ser(UCN)) gene. Neurology 52, 1905-1908 (1999).
50. Hutchin TP, Cortopassi GA. Mitochondrial defects and hearing loss. Cell Mol. Life Sci. 57, 1927-1937 (2000).
51. Jacobs HT, Hutchin TP, Kappi T et al. Mitochondrial DNA mutations in patients with postlingual, nonsyndromic hearing impairment. Eur. J. Hum. Genet. 13, 26-33 (2005). •• Updated review on mitochondrial hearing loss.
52. Bitner-Glindzicz M, Turnpenny P, Hoglund P et al. Further mutations in Brain 4 (POU3F4) clarify the phenotype in the X-linked deafness, DFN3. Hum. Mol. Genet. 4, 1467-1469 (1995).
53. de Kok YJ, Vossenaar ER, Cremers CW et al. Identification of a hot spot for microdeletions in patients with X-linked deafness type 3 (DFN3) 900 kb proximal to the DFN3 gene POU3F4. Hum. Mol. Genet. 5, 1229-1235 (1996).
54. Strom TM, Hortnagel K, Hofmann S et al. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum. Mol. Genet. 7, 2021-2028 (1998).
55. Bespalova IN, Van Camp G, Bom SJ et al. Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss. Hum. Mol. Genet. 10, 2501-2508 (2001).
56. Cryns K, Sivakumaran TA, Van den Ouweland JM et al. Mutational spectrum of the WFS1 gene in Wolfram syndrome, non-syndromic hearing impairment, diabetes mellitus, and psychiatric disease. Hum. Mutat. 22, 275-287 (2003).
57. Robertson NG, Lu L, Heller S et al. Mutations in a novel cochlear gene cause DFNA9, a human non-syndromic deafness with vestibular dysfunction. Nature Genet. 20, 299-303 (1998).
58. Coucke PJ, Van Hauwe P, Kelley PM et al. Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families. Hum. Mol. Genet. 8(7), 1321-1328 (1999).
59. + channel gene, responsible for autosomal dominant hearing loss, cluster in the channel pore region. Am. J. Med. Genet. 93(3), 184-187 (2000).
60. Guilford P, Ben Arab S, Blanchard S et al. Year 2000 position statement: principles and guidelines for early hearing detection and intervention programs. Pediatrics 106, 798-817 (2000). • Position statement regarding universal newborn hearing screening.
61. Baroch KA. Universal newborn hearing screening: fine-tuning the process. Curr. Opin. Otolaryngol. Head Neck Surg. 11, 424-427 (2003).
62. Centers for Disease Control and Prevention (CDC). Infants tested for hearing loss - United States, 1999-2001. Morb. Mortal. Wkly Rep. 52, 981-984 (2003).
63. Yoshinaga-Itano C, Sedey AL, Coulter DK, Mehl AL. Language of early- and later-identified children with hearing loss. Pediatrics 102, 1161-1171 (1998).
64. Armitage IM, Burke JP, Buffin JT. Visual impairment in severe and profound sensorineural deafness. Arch. Dis. Child. 73, 53-56 (1995).
65. Hone SW, Smith RJ. Medical evaluation of pediatric hearing loss. Laboratory, radiographic, and genetic testing. Otolaryngol. Clin. North Am. 35, 751-764 (2002). •• Practical guide to the medical evaluation of children with hearing loss.
66. Preciado DA, Lawson L, Madden C et al. Improved diagnostic effectiveness with a sequential diagnostic paradigm in idiopathic pediatric sensorineural hearing loss. Otol. Neurotol. 26, 610-615 (2005).
67. Smith RJ, Bale JF Jr, White KR. Sensorineural hearing loss in children. Lancet 365(9462), 879-890 (2005). •• Excellent general review of pediatric hearing loss with wonderful figures.
68. Bauer PW, Geers AE, Brenner C, Moog JS, Smith RJ. The effect of GJB2 allele variants on performance after cochlear implantation. Laryngoscope 113, 2135-2140 (2003).
69. Schrijver I. Hereditary non-syndromic sensorineural hearing loss: transforming silence to sound. J. Mol. Diagn. 6, 275-284 (2004).
70. Kenneson A, Van Naarden Braun K, Boyle C. GJB2 (connexin 26) variants and non-syndromic sensorineural hearing loss: a HuGE review. Genet. Med. 4, 258-274 (2002).
71. Alvarez A, del Castillo I, Villamar M et al. High prevalence of the W24X mutation in the gene encoding connexin-26 (GJB2) in Spanish Romani (gypsies) with autosomal recessive non-syndromic hearing loss. Am. J. Med. Genet. A 137, 255-258 (2005).
72. Hamelmann C, Amedofu GK, Albrecht K et al. Pattern of connexin 26 (GJB2) mutations causing sensorineural hearing impairment in Ghana. Hum. Mutat. 18, 84-85 (2001).
73. Pandya A, Arnos KS, Xia XJ et al. Frequency and distribution of GJB2 (connexin 26) and GJB6 (connexin 30) mutations in a large North American repository of deaf probands. Genet. Med. 5, 295-303 (2003).
74. Shafer DN. Genetic hearing test moves ahead: goal is to identify sensorineural hearing loss earlier. The ASHA Leader 5, 27 (2005).
75. Gardner P, Oitmaa E, Messner A, Hoefsloot L, Metspalu A, Schrijver I. Simultaneouos multi-gene mutation detection in patients with sensorineural hearing loss through a novel diagnostic microarray: a new approach for newborn screening follow-up. Pediatrics (2006) (In Press).
76. Green GE, Smith RJ, Bent JP, Cohn ES. Genetic testing to identify deaf newborns. JAMA 284(10), 1245 (2000).
77. Mazzoli M, Newton V, Murgia A et al. Guidelines and recommendations for testing of Cx26 mutations and interpretation of results. Int. J. Pediatr. Otorhinolaryngol. 68, 1397-1398 (2004).
78. OMIM™ - Online Mendelian Inheritance in Man™ www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM
79. Hereditary Hearing Loss Homepage http://webhost.ua.ac.be/hhh
80. Connexin-deafness homepage http://davinci.crg.es/deafness
81. MITOMAP: a human mitochondrial genome database www.mitomap.org
82. GeneTests www.genetests.org